Enalapril
Enalapril, sold under the brand name Vasotec among others, is an ACE inhibitor medication used to treat high blood pressure, diabetic kidney disease, and heart failure. For heart failure, it is generally used with a diuretic, such as furosemide. It is given by mouth or by injection into a vein. Onset of effects are typically within an hour when taken by mouth and last for up to a day.
Clinical data | |
---|---|
Trade names | Vasotec, Renitec, Enacard, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a686022 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth |
Drug class | ACE inhibitor |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 60% (by mouth) |
Metabolism | Liver (to enalaprilat) |
Elimination half-life | 11 hours (enalaprilat) |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.119.661 |
Chemical and physical data | |
Formula | C20H28N2O5 |
Molar mass | 376.453 g·mol−1 |
3D model (JSmol) | |
Melting point | 143 to 144.5 °C (289.4 to 292.1 °F) |
SMILES
| |
| |
(verify) |
Common side effects include headache, tiredness, feeling lightheaded with standing, and cough. Serious side effects include angioedema and low blood pressure. Use during pregnancy is believed to result in harm to the baby. It is in the angiotensin-converting-enzyme (ACE) inhibitor family of medications.
Enalapril was patented in 1978, and came into medical use in 1984. It is on the World Health Organization's List of Essential Medicines. In 2021, it was the 278th most commonly prescribed medication in the United States, with more than 800,000 prescriptions. It is available as a generic medicine.